1-7 of 7
Donald Podoloff
Close
Sort by
Journal Articles

Stem Cell Transplantation with 90 yttrium Ibritumomab Tiuxetan( 90 YIT) in Non-Hodgkin's Lymphoma (NHL): Observations From PET Pre-Treatment Imaging and Responses in Allografted Refractory Follicular Histologies.

Issa F Khouri, Robyn Harrell, Rosamar Valverde, Martin Korbling, Taghi Manshouri, Barry Samuels, Farzaneh Maadani, Grace-Julia Okoroji, Roland L Bassett, Jr., Alousi Amin, Paolo Anderlini, Marcos De Lima, Sergio Giralt, Chitra Hosing, Partow Kebriaei, Uday Popat, Muzaffar Qazilbash, Naoto Ueno, Anne Marie Stachowiak, Bill Erwin, Luis Fayad, Barbara Pro, Nathan Fowler, Peter McLaughlin, Sattva Neelapu, Anas Younes, Richard Champlin, Donald Podoloff
Journal: Blood
Blood (2009) 114 (22): 868.
https://doi.org/10.1182/blood.V114.22.868.868
Published: 2009
Journal Articles

Tositumomab and Iodine I-131 Tositumomab (Bexxar® therapeutic regimen) for Non-Hodgkin's Lymphoma Patients Who Progressed After Treatment with Rituximab: Long Term Follow-up of a Multi-Center Phase II Study.

Sandra J Horning, MD, Anas Younes, MD, Donald Podoloff, MD, Thierry J Horner, PhD, Vanessa C Williams, MS, Christina Vleisides, Michael Goris, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2732.
https://doi.org/10.1182/blood.V114.22.2732.2732
Published: 2009
Journal Articles

Phase II Study of Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin®) in Patients with Relapsed and Refractory Mantle Cell Lymphoma (MCL).

Michael Wang, MD, Yasuhiro Oki, MD, Barbara Pro, MD, Jorge Enrique Romaguera, MD, Maria Alma Rodriguez, MD, Felipe Samaniego, MD, Peter McLaughlin, MD, Frederick Hagemeister, MD, Sattva Neelapu, MD, Donald Podoloff, MD, Barry Samuels, MD, Evelyne Loyer, MD, Yuhong Zhou, MD, Anas Younes, MD
Journal: Blood
Blood (2006) 108 (11): 2714.
https://doi.org/10.1182/blood.V108.11.2714.2714
Published: 2006
Journal Articles

Impact of Holmium-DOTMP on Transplant Outcomes. Results of a Retrospective Single Institution Analysis.

Anna Christoforidou, MD, Patricia Williams, RN, Linda Roden, MD, Ana Aleman, MD, Donna Weber, MD, Floralyn Mendoza, BS, Donald Podoloff, MD, Hazel Breitz, MD, Raymond Alexanian, MD, Richard Champlin, MD, Sergio Giralt, MD
Journal: Blood
Blood (2005) 106 (11): 426.
https://doi.org/10.1182/blood.V106.11.426.426
Published: 2005
Journal Articles

Activity of Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin ® ) in 22 Patients with Relapsed and Refractory Mantle Cell Lymphoma (MCL).

Anas Younes, MD, Barbara Pro, MD, Maria A. Rodriguez, MD, Jorge E. Romaguera, MD, Peter McLaughlin, MD, Michael Wang, MD, Fredrick B. Hagemeister, MD, Nam H. Dang, MD, Sattva Neelapu, MD, Donald Podoloff, MD
Journal: Blood
Blood (2005) 106 (11): 2452.
https://doi.org/10.1182/blood.V106.11.2452.2452
Published: 2005
Journal Articles

Targeted Radiotherapy to the Skeleton Using 166Ho-DOTMP with Autologous Stem Cell Transplantation for Patients with Bone-Only Metastatic Breast Cancer.

Richard Champlin, M.D., Daniel Booser, M.D., Gabriela Rondon, M.D., Patricia Williams, R.N., Richard Wendt, Ph.D., Gabriel Hortobagyi, M.D., Naoto Ueno, M.D., Donald Podoloff, M.D.
Journal: Blood
Blood (2004) 104 (11): 5239.
https://doi.org/10.1182/blood.V104.11.5239.5239
Published: 2004
Journal Articles

166 Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trials

Clinical Trials & Observations
Sergio Giralt, William Bensinger, Mark Goodman, Donald Podoloff, Janet Eary, Richard Wendt, Raymond Alexanian, Donna Weber, David Maloney, Leona Holmberg, Joseph Rajandran, Hazel Breitz, Richard Ghalie, Richard Champlin
Journal: Blood
Blood (2003) 102 (7): 2684–2691.
https://doi.org/10.1182/blood-2002-10-3250
Published: 2003